ClinicalTrials.Veeva

Menu

Outcomes of Neonatal Acute Kidney Injury In Premature Infants

Montefiore Medicine Academic Health System logo

Montefiore Medicine Academic Health System

Status

Completed

Conditions

Chronic Kidney Disease
Acute Kidney Injury

Treatments

Other: Observation

Study type

Observational

Funder types

Other

Identifiers

NCT02375854
2013-2900

Details and patient eligibility

About

The objective of this protocol is to investigate the impact of prematurity, with or without associated acute kidney injury (AKI), on the future risk of chronic kidney disease (CKD) by establishing a patient registry and biorepository. Serum and urine samples will be collected serially from premature infants admitted to the neonatal intensive care unit (NICU) at Albert Einstein College of Medicine/Weiler Hospital and subsequently followed in the NICU follow-up and pediatric nephrology ambulatory subspecialty clinics. The biorepository will be linked to a comprehensive clinical database.

Full description

This is an observational pilot study to enhance understanding of the pathophysiology and epidemiology associated with effects of AKI in premature infants and the role that neonatal AKI plays in future development of CKD. In eligible preterm infants, blood and urine samples will be collected at pre-specified time points during hospitalization and at outpatient follow-up appointments at 6 months, 1 year, 2 years, and 5 years of age and stored in the biorepository. Blood pressure will be measured and recorded at NICU discharge and at all follow-up visits. A renal ultrasound will be performed to monitor renal growth at 2 and 5 years of age. All data will be entered into a comprehensive clinical database, including laboratory results.

Enrollment

25 patients

Sex

All

Ages

1 day to 5 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Preterm infants less than 32 weeks/ gestational age admitted to the Neonatal Intensive Care Unit at Weiler Hospital (The Children's Hospital at Montefiore).

Exclusion criteria

  • Known major congenital anomalies of the kidney and urinary tract (CAKUT) including solitary kidney, cystic dysplasia, multicystic dysplastic kidney, renal hypoplasia, obstructive uropathy
  • Other genetic syndromes or medical conditions that preclude enrollment per judgment of the attending neonatologist

Trial design

25 participants in 1 patient group

Preterm infants
Description:
Less than 32 weeks' gestation
Treatment:
Other: Observation

Trial contacts and locations

1

Loading...

Central trial contact

Mamta Fuloria, MD; Deborah Campbell, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems